The development paves the way for the mass inoculation of the Russian population, even as the final stage of clinical trials to test safety and efficacy continue.
Speaking at a government meeting on state television, Putin said the vaccine, developed by Moscow’s Gamaleya Institute, was safe and that it had even been administered to one of his daughters. Such trials, which require a certain rate of participants catching the virus to observe the vaccine’s effect, are normally considered essential precursors for a vaccine to receive regulatory approval.
پاکستان تازہ ترین خبریں, پاکستان عنوانات
Similar News:آپ اس سے ملتی جلتی خبریں بھی پڑھ سکتے ہیں جو ہم نے دوسرے خبروں کے ذرائع سے جمع کی ہیں۔
ذریعہ: AbbTakk - 🏆 2. / 68 مزید پڑھ »
ذریعہ: AbbTakk - 🏆 2. / 68 مزید پڑھ »
ذریعہ: DunyaNews - 🏆 1. / 83 مزید پڑھ »
ذریعہ: 24NewsHD - 🏆 19. / 51 مزید پڑھ »
ذریعہ: DunyaNews - 🏆 1. / 83 مزید پڑھ »
ذریعہ: 92newschannel - 🏆 21. / 51 مزید پڑھ »